Rxsight Price To Book vs. Price To Sales

RXST Stock  USD 46.88  0.48  1.03%   
Based on Rxsight's profitability indicators, Rxsight may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Rxsight's ability to earn profits and add value for shareholders. At this time, Rxsight's Days Sales Outstanding is comparatively stable compared to the past year. Days Of Sales Outstanding is likely to gain to 97.46 in 2024, whereas Price To Sales Ratio is likely to drop 14.82 in 2024. At this time, Rxsight's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 6.9 M in 2024, despite the fact that Net Loss is likely to grow to (46.2 M).
For Rxsight profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Rxsight to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Rxsight utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Rxsight's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Rxsight over time as well as its relative position and ranking within its peers.
  

Rxsight's Revenue Breakdown by Earning Segment

Check out Your Equity Center.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rxsight. If investors know Rxsight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rxsight listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.81)
Revenue Per Share
3.397
Quarterly Revenue Growth
0.591
Return On Assets
(0.1)
Return On Equity
(0.14)
The market value of Rxsight is measured differently than its book value, which is the value of Rxsight that is recorded on the company's balance sheet. Investors also form their own opinion of Rxsight's value that differs from its market value or its book value, called intrinsic value, which is Rxsight's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rxsight's market value can be influenced by many factors that don't directly affect Rxsight's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rxsight's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rxsight is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rxsight's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Rxsight Price To Sales vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Rxsight's current stock value. Our valuation model uses many indicators to compare Rxsight value to that of its competitors to determine the firm's financial worth.
Rxsight is rated fourth in price to book category among its peers. It is rated second in price to sales category among its peers fabricating about  2.16  of Price To Sales per Price To Book. At this time, Rxsight's Price To Sales Ratio is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Rxsight by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Rxsight Price To Sales vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Rxsight

P/B

 = 

MV Per Share

BV Per Share

 = 
6.75 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Rxsight

P/S

 = 

MV Per Share

Revenue Per Share

 = 
14.58 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Rxsight Price To Sales Comparison

Rxsight is currently under evaluation in price to sales category among its peers.

Rxsight Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Rxsight, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Rxsight will eventually generate negative long term returns. The profitability progress is the general direction of Rxsight's change in net profit over the period of time. It can combine multiple indicators of Rxsight, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5 K-5.2 K
Net Interest Income3.3 M3.4 M
Interest Income6.6 M6.9 M
Operating Income-50.1 M-52.6 M
Net Loss-48.6 M-46.2 M
Income Before Tax-48.6 M-46.2 M
Total Other Income Expense Net1.5 M1.4 M
Net Loss-60.1 M-57.1 M
Net Loss-48.6 M-46.2 M
Income Tax Expense20 K18.9 K
Non Operating Income Net Other1.4 M1.7 M
Change To Netincome14 M14.7 M
Net Loss(1.41)(1.34)
Income Quality 0.86  0.90 
Net Income Per E B T 1.00  0.80 

Rxsight Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Rxsight. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Rxsight position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Rxsight's important profitability drivers and their relationship over time.

Use Rxsight in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rxsight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rxsight will appreciate offsetting losses from the drop in the long position's value.

Rxsight Pair Trading

Rxsight Pair Trading Analysis

The ability to find closely correlated positions to Rxsight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rxsight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rxsight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rxsight to buy it.
The correlation of Rxsight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rxsight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rxsight moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rxsight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Rxsight position

In addition to having Rxsight in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment
Electronic Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.